DEA Cannabis Rescheduling Hearing Raises Questions About Fairness, Transparency, and Federal Bias
DEA’s Latest Cannabis Rescheduling Hearing Sparks Controversy   The DEA cannabis rescheduling hearing has become one of the most closely watched events in the ongoing debate over federal marijuana policy. While many advocates hoped the hearing would provide a balanced examination of the scientific, medical, and economic evidence supporting cannabis rescheduling, critics argue that the […]








